
UK biopharma innovator venture financing surges to $1.1bn in Q1 2025
UK biopharmaceutical companies saw a surge in venture financing for innovator drugs in 2024, with double the total deal value from 2022: $827m in 2022 to $1.7bn in 2024. This growth trend appears set to continue, with the total deal value in the first …